Abstract
As part of a multicenter, open-label, single-arm study of opioid conversion, a take-home survey designed to assess lifetime misuse, abuse, and diversion (MAD) of prescription opioid medications (POM) among chronic pain patients was administered. The study was conducted under IRB approval and a Certificate of Confidentiality to protect sensitive patient information. The take-home MAD survey was provided at baseline and mailed to a third party. The MAD survey included 11 main questions on patient fears of addiction, dependence, and MAD with POM, particularly tampering.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
